Trials / Completed
CompletedNCT00654654
Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Facial Wrinkles and Creases
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Castle Creek Biosciences, LLC. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety profile and the treatment effect of autologous human fibroblasts and placebo when administered to facial wrinkles and creases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Human Fibroblasts (azficel-T) | 1. Collection of 3 mm biopsies 2. Two injection treatments of facial wrinkles and creases 3. Conduct of study assessments |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-04-09
- Last updated
- 2012-03-13
- Results posted
- 2012-03-13
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00654654. Inclusion in this directory is not an endorsement.